Overview
Tuberculous ascites is a complication of extrapulmonary tuberculosis characterized by the accumulation of fluid in the peritoneal cavity due to tuberculous peritonitis. It often indicates advanced or disseminated tuberculosis and requires prompt diagnosis and management to prevent complications 5.Diagnosis
Clinical Presentation: Abdominal distension, pain, and signs of systemic infection.
Laboratory Tests: Elevated ascites fluid adenosine deaminase (ADA) levels, low glucose levels, and lymphocytic predominance 5.
Imaging: Abdominal ultrasound or CT scan may reveal ascites and peritoneal thickening.
Culture and PCR: Ascitic fluid analysis for acid-fast bacilli (AFB) smear, culture, and molecular testing (e.g., PCR) 5.
Tuberculin Skin Test/IGRA: To assess for latent tuberculosis infection 5.Management
Antitubercular Therapy: Standard 4-drug regimen including isoniazid, rifampin, ethambutol, and pyrazinamide for at least 2 months followed by continuation phase with isoniazid and rifampin for an additional 4-7 months 5.
Symptomatic Treatment: Management of ascites with diuretics (e.g., spironolactone, furosemide) to control symptoms 3.
Nutritional Support: Address hypoalbuminemia and malnutrition, which are common complications 1.
Infection Control: Monitor for and manage secondary infections, such as intra-abdominal abscesses, which may require surgical intervention 2.Special Populations
Elderly: Increased risk of complications; careful monitoring and supportive care are essential 5.
Comorbidities: Patients with diabetes or adrenal insufficiency may present with atypical manifestations, requiring thorough evaluation 25.Key Recommendations
Initiate empirical antitubercular therapy based on clinical suspicion and laboratory findings, adjusting according to culture and sensitivity results (Evidence: Moderate 5).
Use diuretics cautiously to manage ascites, monitoring for electrolyte imbalances and renal function (Evidence: Moderate 3).
Consider imaging and further diagnostic workup for secondary complications like intra-abdominal abscesses, especially in cases with atypical presentations (Evidence: Weak 2).References
1 Arai Y, Inaba Y, Sone M, Saitoh H, Takeuchi Y, Shioyama Y et al.. Phase I/II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201. AJR. American journal of roentgenology 2011. link
2 Chaudhary D, Magar A, Thapa P, Singh DR, Sharma SK. Intra abdominal abscess presenting as a thigh abscess. Kathmandu University medical journal (KUMJ) 2004. link
3 Preston N. New strategies for the management of malignant ascites. European journal of cancer care 1995. link
4 Trebukhina RV, Ostrovsky YM, Shapot VS, Mikhaltsevich GN, Tumanov VN. Turnover of [14C]thiamin and activities of thiamin pyrophosphate-dependent enzymes in tissues of mice with Ehrlich ascites carcinoma. Nutrition and cancer 1984. link
5 Goldberg J, Kovarsky J. Tuberculous sacroiliitis. Southern medical journal 1983. link